Michael Miltenberger is a member of the RxBenefits Board of Directors. Michael joined Advent in 2011 as an associate on the healthcare team. Following business school, he rejoined Advent’s Boston office, focusing on healthcare investments. Prior to Advent, he was a consultant at McKinsey & Company in their Washington DC office, serving a range of healthcare and private equity clients.
Michael has worked on Advent’s investments in AccentCare, BioDuro, Cotiviti, First Watch, RxBenefits, Skillsoft, and Syneos Health.
Michael earned a BA, cum laude, from Harvard College and an MBA from Harvard Business School, graduating with High Distinction as a Baker Scholar and a Harvey Fellow.